Found: 43
Select item for more details and to access through your institution.
MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction.
- Published in:
- Cardiovascular Diabetology, 2020, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12933-020-01155-9
- By:
- Publication type:
- Article
The novel inflammatory biomarker GlycA and triglyceride-rich lipoproteins are associated with the presence of subclinical myocardial dysfunction in subjects with type 1 diabetes mellitus.
- Published in:
- Cardiovascular Diabetology, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12933-022-01652-z
- By:
- Publication type:
- Article
Metabolic effect of adrenaline infusion in people with type 1 diabetes and healthy individuals.
- Published in:
- Diabetologia, 2024, v. 67, n. 6, p. 1095, doi. 10.1007/s00125-024-06116-5
- By:
- Publication type:
- Article
Does nocturnal hypoglycaemia really improve quality of life? Reply to Søholm U, Broadley MM, Choudhary P et al [letter].
- Published in:
- 2021
- By:
- Publication type:
- Letter
Effects of continuous glucose monitor-recorded nocturnal hypoglycaemia on quality of life and mood during daily life in type 1 diabetes.
- Published in:
- Diabetologia, 2021, v. 64, n. 4, p. 903, doi. 10.1007/s00125-020-05360-9
- By:
- Publication type:
- Article
Echocardiography improves prediction of major adverse cardiovascular events in a population with type 1 diabetes and without known heart disease: the Thousand & 1 Study.
- Published in:
- Diabetologia, 2019, v. 62, n. 12, p. 2354, doi. 10.1007/s00125-019-05009-2
- By:
- Publication type:
- Article
Breastfeeding at night is rarely followed by hypoglycaemia in women with type 1 diabetes using carbohydrate counting and flexible insulin therapy.
- Published in:
- Diabetologia, 2019, v. 62, n. 3, p. 387, doi. 10.1007/s00125-018-4794-9
- By:
- Publication type:
- Article
Liraglutide enhances insulin secretion and prolongs the remission period in adults with newly diagnosed type 1 diabetes (the NewLira study): A randomized, double‐blind, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2024, v. 26, n. 11, p. 4905, doi. 10.1111/dom.15889
- By:
- Publication type:
- Article
Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open‐label, crossover trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 257, doi. 10.1111/dom.14574
- By:
- Publication type:
- Article
Effects of short‐acting exenatide added three times daily to insulin therapy on bone metabolism in type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 221, doi. 10.1111/dom.14568
- By:
- Publication type:
- Article
Liraglutide changes body composition and lowers added sugar intake in overweight persons with insulin pump‐treated type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 2, p. 212, doi. 10.1111/dom.14567
- By:
- Publication type:
- Article
Effect of short‐acting exenatide administered three times daily on markers of cardiovascular disease in type 1 diabetes: A randomized double‐blind placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1639, doi. 10.1111/dom.14078
- By:
- Publication type:
- Article
Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin‐pump‐treated patients with type 1 diabetes: The Lira Pump trial—a randomized, double‐blinded, placebo‐controlled trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 4, p. 492, doi. 10.1111/dom.13911
- By:
- Publication type:
- Article
Prevalence of heart failure and the diagnostic value of MR‐proANP in outpatients with type 2 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 3, p. 736, doi. 10.1111/dom.13583
- By:
- Publication type:
- Article
Liraglutide as adjunct to insulin treatment in type 1 diabetes does not interfere with glycaemic recovery or gastric emptying rate during hypoglycaemia: A randomized, placebo-controlled, double-blind, parallel-group study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 6, p. 773, doi. 10.1111/dom.12830
- By:
- Publication type:
- Article
Effects of liraglutide on cardiovascular risk factors in patients with type 1 diabetes.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 5, p. 734, doi. 10.1111/dom.12841
- By:
- Publication type:
- Article
Interleukin-1β induced changes in the protein expression of rat islets: A computerized database.
- Published in:
- Electrophoresis, 1997, v. 18, n. 11, p. 2091, doi. 10.1002/elps.1150181136
- By:
- Publication type:
- Article
Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis.
- Published in:
- Diabetes & Vascular Disease Research, 2022, v. 19, n. 5, p. 1, doi. 10.1177/14791641221130043
- By:
- Publication type:
- Article
Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristics.
- Published in:
- Diabetes & Vascular Disease Research, 2016, v. 13, n. 5, p. 321, doi. 10.1177/1479164116645583
- By:
- Publication type:
- Article
Cystic Fibrosis-Related Diabetes.
- Published in:
- Diabetes Care, 2006, v. 29, n. 12, p. 2660, doi. 10.2337/dc06-0654
- By:
- Publication type:
- Article
The impact of upper extremity impairments on work and everyday life of people with type 1 diabetes—A nationwide controlled study.
- Published in:
- Diabetic Medicine, 2024, v. 41, n. 1, p. 1, doi. 10.1111/dme.15158
- By:
- Publication type:
- Article
Prognostic and comparative performance of cardiovascular risk markers in patients with type 2 diabetes.
- Published in:
- Journal of Diabetes, 2021, v. 13, n. 9, p. 754, doi. 10.1111/1753-0407.13172
- By:
- Publication type:
- Article
Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Strain-Dependent Differences in Sensitivity of Rat β-Cells to Interleukin 1β In Vitro and In Vivo.
- Published in:
- Diabetes, 1996, v. 45, n. 6, p. 771, doi. 10.2337/diab.45.6.771
- By:
- Publication type:
- Article
Cloning and expression of cytokine-inducible nitric oxide synthase cDNA from rat islets of Langerhans.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Two-dimensional gel electrophoresis of rat islet proteins. Interleukin 1 beta-induced changes in protein expression are reduced by L-arginine depletion and nicotinamide.
- Published in:
- 1995
- By:
- Publication type:
- journal article
Nicotinamide prevents interleukin-1 effects on accumulated insulin release and nitric oxide production in rat islets of Langerhans.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
- Published in:
- 1990
- By:
- Publication type:
- journal article
Interaction of β-Cell Activity and IL-1 Concentration and Exposure Time in Isolated Rat Islets of Langerhans.
- Published in:
- Diabetes, 1989, v. 38, n. 10, p. 1211, doi. 10.2337/diab.38.10.1211
- By:
- Publication type:
- Article
Insulin Pump Treatment in Adults with Type 1 Diabetes in the Capital Region of Denmark: Design and Cohort Characteristics of the Steno Tech Survey.
- Published in:
- Diabetes Therapy, 2022, v. 13, n. 1, p. 113, doi. 10.1007/s13300-021-01181-0
- By:
- Publication type:
- Article
Glucose Monitoring Metrics in Individuals With Type 1 Diabetes Using Different Treatment Modalities: A Real-World Observational Study.
- Published in:
- Diabetes Care, 2023, v. 46, n. 11, p. 1958, doi. 10.2337/dc23-1137
- By:
- Publication type:
- Article
Upper-Extremity Impairments in Type 1 Diabetes: Results From a Controlled Nationwide Study.
- Published in:
- Diabetes Care, 2023, v. 46, n. 6, p. 1204, doi. 10.2337/dc23-0063
- By:
- Publication type:
- Article
Twelve-Week Treatment With Liraglutide as Add-on to Insulin in Normal-Weight Patients With Poorly Controlled Type 1 Diabetes: A Randomized, Placebo-Controlled, Double-Blind Parallel Study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial.
- Published in:
- 2013
- By:
- Publication type:
- journal article
The Effect of Real-Time Continuous Glucose Monitoring in Pregnant Women With Diabetes.
- Published in:
- Diabetes Care, 2013, v. 36, n. 7, p. 1877, doi. 10.2337/dc12-2360
- By:
- Publication type:
- Article
19. Efficacy and Safety of Liraglutide Added to Insulin in Type 1 Diabetes: The LIRA-1 Trial (277-OR).
- Published in:
- Nederlands Tijdschrift voor Diabetologie (NTvD), 2015, v. 13, n. 3, p. 74, doi. 10.1007/s12467-015-0040-y
- By:
- Publication type:
- Article
131-OR: ADA Presidents' Select Abstract: Effect of Insulin Degludec vs. Insulin Glargine U100 on Occurrence of Nocturnal Hypoglycemia Assessed by Nocturnal Plasma Glucose Profiles in People with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-131-OR
- By:
- Publication type:
- Article
1192-P: Robust Arginine-Stimulated Glucagon Secretion in Patients with Type 1 Diabetes Independent of Diabetes Duration, Age, HbA1c, and Beta-Cell Secretory Capacity.
- Published in:
- Diabetes, 2021, v. 70, p. N.PAG, doi. 10.2337/db21-1192-P
- By:
- Publication type:
- Article
270-OR: Nocturnal Hypoglycemia with Insulin Degludec and Glargine U100 in Patients with Type 1 Diabetes Prone to Severe Nocturnal Hypoglycemia (HypoDeg): A CGM Substudy.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-270-OR
- By:
- Publication type:
- Article
269-OR: Effect of Insulin Degludec on Frequency of Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Nocturnal Severe Hypoglycemia: The HypoDeg Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-269-OR
- By:
- Publication type:
- Article
1094-P: Short-Acting Exenatide and Markers of Cardiovascular Disease in Type 1 Diabetes: A Randomized, Double-Blinded, Placebo-Controlled Trial.
- Published in:
- Diabetes, 2020, v. 69, p. N.PAG, doi. 10.2337/db20-1094-P
- By:
- Publication type:
- Article
59-OR: Liraglutide Preserved Insulin Secretion in Adults with Newly Diagnosed Type 1 Diabetes: The NewLira Trial.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-59-OR
- By:
- Publication type:
- Article
369-P: Effects of Nocturnal Hypoglycemia on Quality of Life and Mood During Daily Life in Type 1 Diabetes—A CGM-Based Analysis.
- Published in:
- Diabetes, 2019, v. 68, p. N.PAG, doi. 10.2337/db19-369-P
- By:
- Publication type:
- Article